PureTech Health plc
PRTC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £4,315 | £750 | £2,090 | £9,979 |
| % Growth | 475.3% | -64.1% | -79.1% | – |
| Cost of Goods Sold | £0 | £93,655 | £152,433 | £110,471 |
| Gross Profit | £4,315 | -£92,905 | -£136,815 | -£100,492 |
| % Margin | 100% | -12,387.3% | -6,546.2% | -1,007% |
| R&D Expenses | £54,280 | £96,235 | £116,113 | £81,521 |
| G&A Expenses | £27,491 | £25,180 | £35,669 | £30,761 |
| SG&A Expenses | £27,491 | £25,180 | £35,669 | £30,761 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £58,639 | -£68,121 | -£90,790 | -£55,083 |
| Operating Expenses | £140,410 | £53,294 | £60,992 | £57,199 |
| Operating Income | -£136,095 | -£146,199 | -£197,807 | -£150,282 |
| % Margin | -3,154% | -19,493.2% | -9,464.4% | -1,506% |
| Other Income/Exp. Net | £159,869 | £110,096 | £105,024 | £91,329 |
| Pre-Tax Income | £23,774 | -£36,103 | -£92,783 | -£58,953 |
| Tax Expense | -£4,008 | £30,525 | -£55,719 | £3,756 |
| Net Income | £53,510 | -£65,697 | -£50,354 | -£60,558 |
| % Margin | 1,240.1% | -8,759.6% | -2,409.3% | -606.9% |
| EPS | 0.2 | -0.24 | -0.18 | -0.21 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| EPS Diluted | 0.2 | -0.24 | -0.18 | -0.21 |
| Weighted Avg Shares Out | 269,657 | 273,738 | 279,746 | 286,591 |
| Weighted Avg Shares Out Dil | 269,657 | 276,303 | 284,759 | 286,591 |
| Supplemental Information | – | – | – | – |
| Interest Income | £22,669 | £16,012 | £5,799 | £214 |
| Interest Expense | £10,037 | £13,488 | £3,953 | £4,714 |
| Depreciation & Amortization | £3,571 | £4,933 | £8,893 | £7,287 |
| EBITDA | £37,382 | -£17,681 | -£79,937 | -£46,952 |
| % Margin | 866.3% | -2,357.5% | -3,824.7% | -470.5% |